| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 44 | 2025 | 732 | 9.830 |
Why?
|
| Inflammasomes | 12 | 2024 | 156 | 3.630 |
Why?
|
| Myocytes, Cardiac | 32 | 2025 | 672 | 2.930 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 22 | 2022 | 241 | 2.740 |
Why?
|
| Heart Atria | 12 | 2024 | 336 | 1.740 |
Why?
|
| Calcium | 22 | 2022 | 1041 | 1.710 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 8 | 2023 | 129 | 1.550 |
Why?
|
| Sarcoplasmic Reticulum | 16 | 2022 | 149 | 1.530 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 14 | 2022 | 138 | 1.510 |
Why?
|
| Anti-Arrhythmia Agents | 5 | 2022 | 226 | 1.360 |
Why?
|
| Calcium Signaling | 14 | 2021 | 249 | 1.310 |
Why?
|
| Arrhythmias, Cardiac | 11 | 2024 | 481 | 1.300 |
Why?
|
| Heart Rate | 7 | 2022 | 580 | 1.030 |
Why?
|
| Sinoatrial Node | 4 | 2024 | 27 | 0.980 |
Why?
|
| Atrial Remodeling | 2 | 2024 | 14 | 0.970 |
Why?
|
| Tachycardia, Ventricular | 7 | 2022 | 254 | 0.950 |
Why?
|
| Animals | 63 | 2025 | 34321 | 0.890 |
Why?
|
| Diet, High-Protein | 1 | 2024 | 4 | 0.840 |
Why?
|
| Signal Transduction | 9 | 2023 | 4666 | 0.790 |
Why?
|
| Mice | 38 | 2025 | 18464 | 0.780 |
Why?
|
| Sick Sinus Syndrome | 1 | 2022 | 16 | 0.770 |
Why?
|
| Interleukin-6 | 2 | 2024 | 414 | 0.750 |
Why?
|
| Myocardium | 10 | 2020 | 874 | 0.740 |
Why?
|
| Disease Models, Animal | 22 | 2025 | 4683 | 0.690 |
Why?
|
| Tacrolimus Binding Proteins | 4 | 2016 | 72 | 0.680 |
Why?
|
| Heart Failure | 12 | 2024 | 2305 | 0.670 |
Why?
|
| MicroRNAs | 4 | 2015 | 894 | 0.670 |
Why?
|
| Automation | 2 | 2023 | 67 | 0.660 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 177 | 0.650 |
Why?
|
| Berberine | 3 | 2010 | 9 | 0.640 |
Why?
|
| Cyclic AMP Response Element Modulator | 4 | 2022 | 23 | 0.640 |
Why?
|
| Proteostasis | 1 | 2020 | 36 | 0.630 |
Why?
|
| Bioprinting | 1 | 2019 | 13 | 0.620 |
Why?
|
| Behcet Syndrome | 1 | 2019 | 14 | 0.610 |
Why?
|
| Calcium-Binding Proteins | 6 | 2019 | 328 | 0.600 |
Why?
|
| Isoproterenol | 5 | 2022 | 89 | 0.570 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 837 | 0.560 |
Why?
|
| Heart Conduction System | 4 | 2024 | 161 | 0.560 |
Why?
|
| Mice, Knockout | 17 | 2025 | 3860 | 0.560 |
Why?
|
| Humans | 61 | 2026 | 131410 | 0.550 |
Why?
|
| Inflammation | 3 | 2022 | 1488 | 0.520 |
Why?
|
| Down-Regulation | 7 | 2023 | 659 | 0.520 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2022 | 833 | 0.520 |
Why?
|
| Tetracaine | 1 | 2016 | 11 | 0.510 |
Why?
|
| Hyperuricemia | 1 | 2016 | 38 | 0.490 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 731 | 0.490 |
Why?
|
| Fibroblasts | 2 | 2020 | 864 | 0.490 |
Why?
|
| Uric Acid | 1 | 2016 | 110 | 0.480 |
Why?
|
| Channelopathies | 1 | 2016 | 12 | 0.480 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 998 | 0.450 |
Why?
|
| Action Potentials | 7 | 2021 | 471 | 0.440 |
Why?
|
| Gene Expression Regulation | 6 | 2013 | 2354 | 0.440 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2015 | 45 | 0.440 |
Why?
|
| Patch-Clamp Techniques | 9 | 2018 | 279 | 0.430 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 1839 | 0.430 |
Why?
|
| Epigenomics | 1 | 2015 | 186 | 0.430 |
Why?
|
| Mice, Transgenic | 12 | 2022 | 2363 | 0.420 |
Why?
|
| Pyrazoles | 4 | 2010 | 357 | 0.410 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 6 | 2018 | 38 | 0.400 |
Why?
|
| Biomarkers | 5 | 2024 | 3400 | 0.400 |
Why?
|
| Electric Stimulation | 2 | 2012 | 249 | 0.390 |
Why?
|
| Physical Endurance | 1 | 2013 | 42 | 0.390 |
Why?
|
| Propanolamines | 1 | 2012 | 18 | 0.390 |
Why?
|
| RNA, Messenger | 4 | 2022 | 2568 | 0.380 |
Why?
|
| Carbazoles | 1 | 2012 | 30 | 0.380 |
Why?
|
| Organoids | 3 | 2025 | 307 | 0.370 |
Why?
|
| Long QT Syndrome | 2 | 2012 | 83 | 0.370 |
Why?
|
| Morpholines | 1 | 2012 | 68 | 0.370 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 86 | 0.370 |
Why?
|
| Obesity | 4 | 2023 | 2378 | 0.370 |
Why?
|
| Endothelin Receptor Antagonists | 2 | 2010 | 13 | 0.370 |
Why?
|
| Exercise Test | 1 | 2013 | 243 | 0.360 |
Why?
|
| Tissue Scaffolds | 2 | 2025 | 92 | 0.360 |
Why?
|
| Hydrogels | 2 | 2024 | 101 | 0.350 |
Why?
|
| Case-Control Studies | 5 | 2025 | 3448 | 0.340 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 253 | 0.340 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2010 | 273 | 0.330 |
Why?
|
| Endothelins | 1 | 2010 | 7 | 0.330 |
Why?
|
| Receptor, Endothelin A | 3 | 2008 | 11 | 0.320 |
Why?
|
| Potassium Channels | 1 | 2010 | 156 | 0.300 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 568 | 0.300 |
Why?
|
| Phosphorylation | 11 | 2020 | 1569 | 0.300 |
Why?
|
| Vitamin E | 1 | 2008 | 63 | 0.280 |
Why?
|
| Aged | 13 | 2025 | 21215 | 0.280 |
Why?
|
| Rats | 11 | 2015 | 3454 | 0.280 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 40 | 0.270 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2025 | 16 | 0.270 |
Why?
|
| Mutation | 9 | 2024 | 6177 | 0.270 |
Why?
|
| Cells, Cultured | 8 | 2020 | 2970 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 4761 | 0.260 |
Why?
|
| High-Throughput Screening Assays | 2 | 2025 | 117 | 0.260 |
Why?
|
| Hypertension, Pulmonary | 2 | 2008 | 463 | 0.250 |
Why?
|
| Male | 28 | 2025 | 65108 | 0.250 |
Why?
|
| Ion Channels | 1 | 2007 | 206 | 0.240 |
Why?
|
| Knowledge Bases | 1 | 2026 | 40 | 0.240 |
Why?
|
| Cardiomyopathies | 3 | 2022 | 513 | 0.240 |
Why?
|
| Sodium-Calcium Exchanger | 3 | 2016 | 22 | 0.240 |
Why?
|
| Hypoxia | 2 | 2023 | 245 | 0.240 |
Why?
|
| Atrial Appendage | 2 | 2025 | 76 | 0.240 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1957 | 0.240 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 382 | 0.230 |
Why?
|
| Interleukin-1beta | 2 | 2023 | 159 | 0.230 |
Why?
|
| Neoplasms | 3 | 2025 | 2969 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 3411 | 0.220 |
Why?
|
| Membrane Potentials | 5 | 2013 | 297 | 0.220 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2018 | 69 | 0.220 |
Why?
|
| Mitochondria, Heart | 1 | 2025 | 51 | 0.220 |
Why?
|
| Rheology | 1 | 2024 | 25 | 0.220 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2024 | 8 | 0.210 |
Why?
|
| NFATC Transcription Factors | 2 | 2022 | 37 | 0.210 |
Why?
|
| Cancer Vaccines | 1 | 2025 | 191 | 0.210 |
Why?
|
| Dioxygenases | 1 | 2024 | 72 | 0.210 |
Why?
|
| Gene Knock-In Techniques | 4 | 2019 | 122 | 0.210 |
Why?
|
| Glucosides | 1 | 2024 | 54 | 0.200 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2023 | 40 | 0.200 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 75 | 0.200 |
Why?
|
| Mitochondrial Diseases | 1 | 2025 | 149 | 0.200 |
Why?
|
| Coculture Techniques | 2 | 2023 | 233 | 0.200 |
Why?
|
| Fibrosis | 3 | 2022 | 412 | 0.200 |
Why?
|
| Female | 23 | 2025 | 71030 | 0.190 |
Why?
|
| Cytoplasm | 1 | 2024 | 253 | 0.190 |
Why?
|
| Transcription Factors | 3 | 2019 | 2436 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2010 | 1148 | 0.190 |
Why?
|
| HEK293 Cells | 1 | 2025 | 808 | 0.190 |
Why?
|
| Dendritic Cells | 1 | 2025 | 439 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2022 | 152 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 178 | 0.180 |
Why?
|
| Heart Ventricles | 2 | 2018 | 768 | 0.180 |
Why?
|
| Folic Acid | 1 | 2024 | 286 | 0.180 |
Why?
|
| Calmodulin | 3 | 2017 | 208 | 0.180 |
Why?
|
| Adiposity | 1 | 2023 | 207 | 0.180 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.180 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 17 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 387 | 0.180 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 2081 | 0.170 |
Why?
|
| Nanoparticles | 1 | 2024 | 293 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2022 | 179 | 0.170 |
Why?
|
| Ankyrins | 2 | 2012 | 96 | 0.170 |
Why?
|
| Ataxia | 1 | 2022 | 169 | 0.170 |
Why?
|
| Guinea Pigs | 3 | 2010 | 157 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 600 | 0.160 |
Why?
|
| Dependovirus | 2 | 2019 | 157 | 0.160 |
Why?
|
| DNA | 2 | 2017 | 1443 | 0.160 |
Why?
|
| Receptors, Thrombin | 1 | 2020 | 12 | 0.160 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2020 | 20 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2022 | 362 | 0.160 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2019 | 10 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2019 | 832 | 0.160 |
Why?
|
| Silk | 1 | 2019 | 3 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2024 | 777 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2021 | 359 | 0.150 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 15 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 1217 | 0.150 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 309 | 0.150 |
Why?
|
| Endothelin B Receptor Antagonists | 2 | 2008 | 3 | 0.150 |
Why?
|
| Endothelin A Receptor Antagonists | 2 | 2008 | 7 | 0.150 |
Why?
|
| Sorting Nexins | 1 | 2018 | 8 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 111 | 0.140 |
Why?
|
| Protein Phosphatase 1 | 2 | 2019 | 53 | 0.140 |
Why?
|
| Oxides | 1 | 2018 | 16 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 634 | 0.140 |
Why?
|
| Genetic Vectors | 2 | 2019 | 901 | 0.140 |
Why?
|
| Methylamines | 1 | 2018 | 22 | 0.140 |
Why?
|
| Sodium | 1 | 2019 | 281 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 704 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2019 | 147 | 0.140 |
Why?
|
| Hypertension | 2 | 2021 | 1357 | 0.140 |
Why?
|
| Collagen | 1 | 2019 | 289 | 0.140 |
Why?
|
| Cell Line | 2 | 2020 | 2604 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 274 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2019 | 168 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 699 | 0.140 |
Why?
|
| Exercise | 1 | 2024 | 865 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2022 | 379 | 0.130 |
Why?
|
| Neutrophils | 1 | 2019 | 370 | 0.130 |
Why?
|
| Seizures | 1 | 2022 | 887 | 0.130 |
Why?
|
| Risk Factors | 4 | 2021 | 10947 | 0.130 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 164 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 343 | 0.130 |
Why?
|
| Cell Survival | 1 | 2019 | 853 | 0.130 |
Why?
|
| Thiazepines | 1 | 2016 | 7 | 0.130 |
Why?
|
| Antioxidants | 2 | 2010 | 336 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1236 | 0.120 |
Why?
|
| Gene Editing | 1 | 2018 | 227 | 0.120 |
Why?
|
| Aging | 2 | 2022 | 1261 | 0.120 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 85 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 98 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 904 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2015 | 20 | 0.120 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2015 | 31 | 0.110 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 39 | 0.110 |
Why?
|
| Potassium | 1 | 2016 | 270 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1624 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2012 | 1018 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2016 | 810 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2015 | 226 | 0.110 |
Why?
|
| Sulfonamides | 3 | 2018 | 296 | 0.110 |
Why?
|
| COUP Transcription Factor I | 1 | 2013 | 54 | 0.100 |
Why?
|
| Ear, Inner | 1 | 2013 | 42 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2018 | 726 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cardiomegaly | 2 | 2012 | 117 | 0.100 |
Why?
|
| Middle Aged | 9 | 2025 | 28807 | 0.100 |
Why?
|
| Apoptosis | 1 | 2019 | 1862 | 0.100 |
Why?
|
| Cytokines | 1 | 2018 | 1346 | 0.090 |
Why?
|
| Disease Progression | 3 | 2014 | 2204 | 0.090 |
Why?
|
| NADPH Oxidases | 2 | 2013 | 108 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 103 | 0.090 |
Why?
|
| Ventricular Fibrillation | 1 | 2012 | 59 | 0.090 |
Why?
|
| Electrocardiography | 4 | 2010 | 983 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1409 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 886 | 0.090 |
Why?
|
| Ventricular Remodeling | 2 | 2012 | 155 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1170 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2011 | 163 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 380 | 0.090 |
Why?
|
| Time Factors | 4 | 2014 | 6272 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2008 | 139 | 0.080 |
Why?
|
| Permeability | 2 | 2024 | 120 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2011 | 148 | 0.080 |
Why?
|
| Calcium Channel Blockers | 2 | 2008 | 111 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1614 | 0.080 |
Why?
|
| Mice, Inbred mdx | 3 | 2018 | 44 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2007 | 319 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 459 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 158 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1397 | 0.080 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 36 | 0.080 |
Why?
|
| Cornus | 1 | 2008 | 1 | 0.070 |
Why?
|
| Triterpenes | 1 | 2008 | 22 | 0.070 |
Why?
|
| Oxidation-Reduction | 3 | 2018 | 442 | 0.070 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2008 | 17 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2008 | 11 | 0.070 |
Why?
|
| Guanidines | 1 | 2008 | 24 | 0.070 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2008 | 16 | 0.070 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2008 | 12 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 39 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2008 | 116 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1831 | 0.070 |
Why?
|
| Vasoconstriction | 1 | 2007 | 95 | 0.070 |
Why?
|
| Torsades de Pointes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Phenethylamines | 1 | 2007 | 16 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2008 | 199 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 2869 | 0.060 |
Why?
|
| Naphthalenes | 1 | 2007 | 38 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 230 | 0.060 |
Why?
|
| Oxidative Stress | 4 | 2018 | 804 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 746 | 0.060 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 248 | 0.060 |
Why?
|
| Proteomics | 2 | 2021 | 604 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 366 | 0.060 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 518 | 0.060 |
Why?
|
| Interferon Type I | 1 | 2025 | 115 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 561 | 0.060 |
Why?
|
| Biomimetic Materials | 1 | 2024 | 15 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2026 | 160 | 0.060 |
Why?
|
| Mucus | 1 | 2024 | 38 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 441 | 0.050 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2024 | 60 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2025 | 132 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2025 | 321 | 0.050 |
Why?
|
| Aorta | 1 | 2007 | 529 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 803 | 0.050 |
Why?
|
| United Kingdom | 1 | 2024 | 252 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 291 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 536 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 211 | 0.050 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Echocardiography | 2 | 2024 | 1138 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2025 | 404 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2025 | 411 | 0.050 |
Why?
|
| Internet | 1 | 2026 | 419 | 0.050 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 156 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2025 | 460 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2023 | 119 | 0.050 |
Why?
|
| Troponin T | 1 | 2024 | 254 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 139 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 48 | 0.050 |
Why?
|
| Lipolysis | 1 | 2022 | 76 | 0.050 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2022 | 73 | 0.050 |
Why?
|
| Pericardium | 1 | 2023 | 105 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 119 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2022 | 140 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 327 | 0.040 |
Why?
|
| Rabbits | 2 | 2016 | 633 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 451 | 0.040 |
Why?
|
| Adipocytes | 1 | 2022 | 173 | 0.040 |
Why?
|
| Monocytes | 1 | 2023 | 337 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 276 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 421 | 0.040 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 310 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12923 | 0.040 |
Why?
|
| Software | 1 | 2026 | 752 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1565 | 0.040 |
Why?
|
| Proteins | 1 | 2026 | 1025 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2021 | 146 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2022 | 435 | 0.040 |
Why?
|
| Child | 4 | 2024 | 26224 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2023 | 354 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2023 | 494 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 346 | 0.040 |
Why?
|
| Phenotype | 3 | 2018 | 4516 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 49 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 489 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1610 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 43 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 226 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Macrophages | 1 | 2023 | 663 | 0.040 |
Why?
|
| Receptor, Endothelin B | 2 | 2008 | 6 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 31 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2025 | 1272 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 34 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 101 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 72 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 157 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 713 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2009 | 132 | 0.040 |
Why?
|
| NADPH Oxidase 2 | 1 | 2018 | 38 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2019 | 350 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 263 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 283 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 621 | 0.030 |
Why?
|
| Arteries | 1 | 2018 | 209 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 224 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1069 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 496 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 588 | 0.030 |
Why?
|
| Dantrolene | 1 | 2016 | 5 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 665 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 401 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 2016 | 121 | 0.030 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2015 | 10 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2015 | 51 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 2464 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 95 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2013 | 4 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 865 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 113 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 67 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 116 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2024 | 6481 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 530 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2015 | 262 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 112 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2012 | 25 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2013 | 134 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 410 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2013 | 171 | 0.020 |
Why?
|
| Adult | 3 | 2025 | 31628 | 0.020 |
Why?
|
| Benzylamines | 1 | 2012 | 22 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 272 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 73 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2012 | 46 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 36 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1710 | 0.020 |
Why?
|
| Infant | 2 | 2022 | 13292 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 421 | 0.020 |
Why?
|
| Caffeine | 1 | 2012 | 66 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 144 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 163 | 0.020 |
Why?
|
| Sarcolemma | 1 | 2010 | 13 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2010 | 38 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2013 | 684 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 46 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 204 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 362 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2010 | 44 | 0.020 |
Why?
|
| Theophylline | 1 | 2009 | 23 | 0.020 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2009 | 8 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2009 | 9 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 356 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 79 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7571 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 59 | 0.020 |
Why?
|
| Goats | 1 | 2009 | 60 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 692 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 609 | 0.020 |
Why?
|
| Monocrotaline | 1 | 2008 | 2 | 0.020 |
Why?
|
| Streptozocin | 1 | 2008 | 26 | 0.020 |
Why?
|
| Nifedipine | 1 | 2008 | 21 | 0.020 |
Why?
|
| Epinephrine | 1 | 2009 | 150 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2008 | 40 | 0.020 |
Why?
|
| Arterioles | 1 | 2008 | 38 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 2008 | 14 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 547 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 91 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1123 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2008 | 153 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 145 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2142 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 1231 | 0.020 |
Why?
|
| Methoxamine | 1 | 2007 | 3 | 0.020 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2007 | 8 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 2563 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 617 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17628 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 39 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 50 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 824 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2008 | 230 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3613 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2022 | 15037 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1024 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 2783 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 835 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 20902 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3909 | 0.010 |
Why?
|
| Algorithms | 1 | 2007 | 1683 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 10081 | 0.010 |
Why?
|